AngioDynamics Inc. (ANGO) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
14 PLAZA DRIVE LATHAM, NY 12110 |
| State of Incorp. | DE |
| Fiscal Year End | May 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 11/30/2025 MRQ | 5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 55,893 | 76,056 | 44,620 | 28,825 | 48,161 | 54,435 | |||
| Cash and cash equivalent | 55,893 | 76,056 | 44,620 | 28,825 | 48,161 | 54,435 | |||
| Receivables | 42,890 | 43,610 | 52,826 | 52,304 | 35,405 | 31,263 | |||
| Inventory, net of allowances, customer advances and progress billings | 62,006 | 60,616 | 55,325 | 51,392 | 48,614 | 59,905 | |||
| Inventory | 62,006 | 60,616 | 55,325 | 51,392 | 48,614 | 59,905 | |||
| Prepaid expense | 3,319 | 2,762 | 1,293 | 2,441 | 2,028 | 2,484 | |||
| Disposal group, including discontinued operation | 6,154 | ||||||||
| Other undisclosed current assets | 4,216 | 10,209 | 3,324 | 8,383 | 6,671 | 4,826 | |||
| Total current assets: | 168,324 | 193,253 | 163,542 | 143,345 | 140,879 | 152,913 | |||
| Noncurrent Assets | |||||||||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 32,300 | 35,666 | 44,384 | 45,005 | 37,073 | 28,312 | |||
| Intangible asset, including goodwill, after accumulated amortization | 69,116 | 77,383 | 270,382 | 353,438 | 370,293 | 397,651 | |||
| Goodwill | 159,238 | 201,058 | 201,316 | 200,515 | |||||
| Intangible asset, excluding goodwill, after accumulated amortization | 69,116 | 77,383 | 111,144 | 152,380 | 168,977 | 197,136 | |||
| Disposal group, including discontinued operation, noncurrent assets | 43,653 | ||||||||
| Other noncurrent assets | 10,404 | 11,369 | 10,676 | 10,963 | 13,193 | 15,338 | |||
| Total noncurrent assets: | 111,820 | 124,418 | 369,095 | 409,406 | 420,559 | 441,301 | |||
| TOTAL ASSETS: | 280,144 | 317,671 | 532,637 | 552,751 | 561,438 | 594,214 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 68,809 | 78,849 | 67,062 | 62,889 | 55,089 | 48,476 | |||
| Accounts payable | 33,291 | 37,751 | 40,445 | 28,047 | 19,630 | 19,096 | |||
| Accrued liabilities | 35,518 | 41,098 | 26,617 | 34,842 | 35,459 | 29,380 | |||
| Business combination, contingent consideration, liability | 4,728 | 14,761 | 8,783 | 836 | |||||
| Other liabilities | 7,388 | 7,578 | 2,002 | 2,652 | 2,495 | 2,133 | |||
| Total current liabilities: | 76,197 | 91,155 | 83,825 | 74,324 | 57,584 | 51,445 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 4,703 | 7,319 | 48,345 | ||||||
| Long-term debt, excluding current maturities | 40,000 | ||||||||
| Liabilities, other than long-term debt | 16,904 | 20,017 | 11,201 | 12,901 | 24,442 | 23,840 | |||
| Other liabilities | 16,904 | 16,078 | 3,350 | 4,736 | 8,701 | 9,029 | |||
| Operating lease, liability | 3,939 | 3,316 | 4,703 | 7,319 | 8,345 | ||||
| Business combination, contingent consideration, liability | 4,535 | 8,165 | 15,741 | 14,811 | |||||
| Other undisclosed noncurrent liabilities | 4,073 | 913 | 59,315 | 36,334 | 32,636 | 15,712 | |||
| Total noncurrent liabilities: | 20,977 | 20,930 | 70,516 | 53,938 | 64,397 | 87,897 | |||
| Total liabilities: | 97,174 | 112,085 | 154,341 | 128,262 | 121,981 | 139,342 | |||
| Equity | |||||||||
| Equity, attributable to parent | 182,970 | 205,586 | 378,296 | 424,489 | 439,457 | 454,872 | |||
| Common stock | 385 | 385 | 382 | 380 | 377 | 374 | |||
| Treasury stock, value | (7,381) | (5,714) | (5,714) | (5,714) | (5,714) | (5,714) | |||
| Additional paid in capital | 621,186 | 610,484 | 599,206 | 586,879 | 573,507 | 561,871 | |||
| Accumulated other comprehensive income (loss) | (2,023) | (4,365) | (4,723) | 1,357 | 3,153 | (1,341) | |||
| Accumulated deficit | (429,197) | (395,204) | (210,855) | (158,413) | (131,866) | (100,318) | |||
| Total equity: | 182,970 | 205,586 | 378,296 | 424,489 | 439,457 | 454,872 | |||
| TOTAL LIABILITIES AND EQUITY: | 280,144 | 317,671 | 532,637 | 552,751 | 561,438 | 594,214 | |||
Income Statement (P&L) ($ in thousands)
| 11/30/2025 TTM | 5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 292,498 | 303,914 | 338,752 | 316,219 | 291,010 | 264,157 | ||
| Cost of revenue (Cost of Product and Service Sold) | (134,793) | (149,216) | (164,506) | (150,487) | (134,222) | (113,885) | ||
| Gross profit: | 157,705 | 154,698 | 174,246 | 165,732 | 156,788 | 150,272 | ||
| Operating expenses | (197,659) | (401,632) | (225,427) | (194,203) | (192,071) | (317,370) | ||
| Other undisclosed operating income | 54,499 | |||||||
| Operating loss: | (39,954) | (192,435) | (51,181) | (28,471) | (35,283) | (167,098) | ||
| Nonoperating income (expense) | 4,944 | (817) | (554) | (790) | 92 | (1,037) | ||
| Other nonoperating income (expense) | 4,944 | (817) | (554) | (790) | 92 | (1,037) | ||
| Interest and debt expense | (200) | 1,614 | (2,702) | (688) | (861) | (907) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 907 | |||||||
| Loss from continuing operations before equity method investments, income taxes: | (35,210) | (191,638) | (54,437) | (29,949) | (36,052) | (168,135) | ||
| Other undisclosed income from continuing operations before income taxes | 1,178 | |||||||
| Loss from continuing operations before income taxes: | (34,032) | (191,638) | (54,437) | (29,949) | (36,052) | (168,135) | ||
| Income tax benefit | 39 | 7,289 | 1,995 | 3,402 | 4,504 | 1,348 | ||
| Loss from continuing operations: | (33,993) | (184,349) | (52,442) | (26,547) | (31,548) | (166,787) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (26,547) | (31,548) | (166,787) | |
| Net loss available to common stockholders, diluted: | (33,993) | (184,349) | (52,442) | (26,547) | (31,548) | (166,787) | ||
Comprehensive Income ($ in thousands)
| 11/30/2025 TTM | 5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (33,993) | (184,349) | (52,442) | (26,547) | (31,548) | (166,787) | ||
| Other comprehensive income (loss) | 2,342 | 358 | (6,080) | (1,796) | 4,494 | 11 | ||
| Comprehensive loss, net of tax, attributable to parent: | (31,651) | (183,991) | (58,522) | (28,343) | (27,054) | (166,776) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.